Leaderboards/Platelet Disorders and Treatments

Platelet Disorders and Treatments

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Eun‐Ju Lee
NewYork–Presbyterian Hospital
2
Omid Seidizadeh
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
3
Joel T. Gibson
The Royal Melbourne Hospital
4
Serena Omo‐Lamai
University of Pennsylvania
5
Zhong‐Shi Lyu
Peking University
6
Rebecca A Risman
Rutgers, The State University of New Jersey
7
Dino Mehic
Medical University of Vienna
8
Afra Anjum
LMU Klinikum
9
Alex Bourguignon
Centre Hospitalier de l’Université de Montréal
10
Keumyeon Kim
The Medical Device (United Kingdom)

Papers

1
Physicochemical Targeting of Lipid Nanoparticles to the Lungs Induces Clotting: Mechanisms and Solutions
Advanced Materials|2024
101 cit.
2
Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape
Nature Nanotechnology|2025
55 cit.
3
Comprehensive Analysis of the Role of Fibrinogen and Thrombin in Clot Formation and Structure for Plasma and Purified Fibrinogen
Biomolecules|2024
49 cit.
4
Aging platelets shift their hemostatic properties to inflammatory functions
Blood|2025
40 cit.
5
Global prevalence of hereditary thrombotic thrombocytopenic purpura determined by genetic analysis
Blood Advances|2024
24 cit.
6
Internal fibrinolysis of fibrin clots is driven by pore expansion
Scientific Reports|2024
22 cit.
7
Targeting of nanoparticles to the cerebral vasculature after traumatic brain injury
PLoS ONE|2024
12 cit.
8
Type 2M/2A von Willebrand disease: a shared phenotype between type 2M and 2A
Blood Advances|2024
11 cit.
9
Plasmin generation analysis in patients with bleeding disorder of unknown cause
Blood Advances|2024
10 cit.
10
Platelet function analyzer (PFA-100) in patients with mild-to-moderate bleeding disorders and bleeding disorder of unknown cause
Journal of Thrombosis and Haemostasis|2025
9 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Adam S. Butterworth
University of Cambridge
2
Ishac Nazy
McMaster University
3
Ian Maze
Allen Institute for Brain Science
4
Matthew T. Harper
University of Cambridge
5
Lonneke A. van Vught
University of Amsterdam
6
Alessandra Metelli
Medical University of South Carolina
7
Nicola M. Tomas
Universität Hamburg
8
Frank A. W. Coumans
University of Amsterdam
9
Timothy J. Watts
Homerton University Hospital NHS Foundation Trust
10
Carlos J. Bosques
Momenta Pharmaceuticals (United States)

Papers

1
The classical pathway triggers pathogenic complement activation in membranous nephropathy
Nature Communications|2023
97 cit.
2
Bidirectional histone monoaminylation dynamics regulate neural rhythmicity
Nature|2025
47 cit.
3
Endothelial inflammation and neutrophil transmigration are modulated by extracellular matrix composition in an inflammation-on-a-chip model
Scientific Reports|2022
45 cit.
4
An antigen-specific chimeric autoantibody receptor (CAAR) NK cell strategy for the elimination of anti-PLA2R1 and anti-THSD7A antibody-secreting cells
Kidney International|2024
45 cit.
5
Histone H3 dopaminylation in ventral tegmental area underlies heroin-induced transcriptional and behavioral plasticity in male rats
Neuropsychopharmacology|2022
42 cit.
6
Histone serotonylation in dorsal raphe nucleus contributes to stress- and antidepressant-mediated gene expression and behavior
Nature Communications|2024
42 cit.
7
Chromatin profiling in human neurons reveals aberrant roles for histone acetylation and BET family proteins in schizophrenia
Nature Communications|2022
36 cit.
8
Podocyte expression of human phospholipase A2 receptor 1 causes immune-mediated membranous nephropathy in mice
Kidney International|2022
35 cit.
9
Investigation of anti-PF4 versus anti-PF4/heparin reactivity using fluid-phase enzyme immunoassay for 4 anti-PF4 disorders: classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, vaccine-induced immune thrombotic thrombocytopenia, and spontaneous HIT
Journal of Thrombosis and Haemostasis|2023
34 cit.
10
VITT-like Monoclonal Gammopathy of Thrombotic Significance
New England Journal of Medicine|2025
34 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Timothy A. Springer
Harvard University
2
Zaverio M. Ruggeri
Scripps Research Institute
3
Steve P. Watson
University of Nottingham
4
Steven A. Krilis
Brigham and Women's Hospital
5
Denisa D. Wagner
Boston Children's Hospital
6
James B. Bussel
Cornell University
7
Richard H. Aster
Versiti Blood Center of Wisconsin
8
Napoleone Ferrara
Unknown
9
Mark H. Ginsberg
University of California San Diego
10
Sanford J. Shattil
University of California San Diego

Papers

1
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
Journal of Thrombosis and Haemostasis|2006
7.1k cit.
2
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Science|1989
5k cit.
3
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
Nature|1993
3.6k cit.
4
Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).
The Journal of Immunology|1986
2.5k cit.
5
Extracellular DNA traps promote thrombosis
Proceedings of the National Academy of Sciences|2010
2.4k cit.
6
Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
Biochemical and Biophysical Research Communications|1989
2.3k cit.
7
Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins
Cell|1991
2.2k cit.
8
Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway
Journal of Biological Chemistry|1998
2k cit.
9
Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1)
Cell|1987
1.7k cit.
10
Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice
Proceedings of the National Academy of Sciences|1998
1.7k cit.

Reagents for Platelet Disorders and Treatments

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling Technology

Keratin 14 (E7J5W) Rabbit Monoclonal Antibody

Cited in 8 papers
#30731$161,351
View Evidence →
Agilent/Dako

Fibrinogen

Cited in 8 papers
#F0111
View Evidence →
Cell Signaling TechnologyEvidence 66

His-Tag (D3I1O) Horse Chimeric Monoclonal Antibody

Cited in 8 papers
#25715$161,386
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 64

Phospho-Stat5 (Tyr694) (D47E7) Rabbit Monoclonal Antibody (SignalFlex™ Pacific Blue™ Conjugate)

Cited in 11 papers
#23382$486
View Evidence →
Cell Signaling TechnologyEvidence 65

Bim (C34C5) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

Cited in 11 papers
#94805$465
View Evidence →
Cell Signaling TechnologyEvidence 68

ANP32A (D7Z5U) Rabbit Monoclonal Antibody

Cited in 10 papers
#15491$161,351
View Evidence →